0001567619-19-018532.txt : 20190919
0001567619-19-018532.hdr.sgml : 20190919
20190919161059
ACCESSION NUMBER: 0001567619-19-018532
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190919
DATE AS OF CHANGE: 20190919
EFFECTIVENESS DATE: 20190919
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERAX BIOMEDICAL INC
CENTRAL INDEX KEY: 0001161304
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-349251
FILM NUMBER: 191101855
BUSINESS ADDRESS:
STREET 1: 148 BARTLETT STREET
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: 508-755-7049
MAIL ADDRESS:
STREET 1: 148 BARTLETT STREET
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
D
1
primary_doc.xml
X0708
D
LIVE
0001161304
VERAX BIOMEDICAL INC
c/o Verax Biomedical Incorporated
148 BARTLETT STREET
MARLBOROUGH
MA
MASSACHUSETTS
01752
(508) 755-7029
DELAWARE
None
None
Corporation
true
James
Lousararian
c/o Verax Biomedical Incorporated
148 Bartlett Street
Marlborough
MA
MASSACHUSETTS
01752
Executive Officer
Director
Paul
Ragusa
c/o Verax Biomedical Incorporated
148 Bartlett Street
Marlborough
MA
MASSACHUSETTS
01752
Executive Officer
Marc
Goldberg
c/o Verax Biomedical Incorporated
148 Bartlett Street
Marlborough
MA
MASSACHUSETTS
01752
Director
Robert
Flanagan
c/o Verax Biomedical Incorporated
148 Bartlett Street
Marlborough
MA
MASSACHUSETTS
01752
Director
Joe
Sanders
c/o Verax Biomedical Incorporated
148 Bartlett Street
Marlborough
MA
MASSACHUSETTS
01752
Director
Biotechnology
Decline to Disclose
- 06b
false
2019-09-05
true
true
true
true
false
0
Four Points Capital Partners LLC
43149
Thomas Frederick Zipser
5248930
10 East 40th Street
Suite 1910
New York
NY
NEW YORK
10016
MA
MASSACHUSETTS
false
10538912
2538912
8000000
false
5
425000
0
0
false
VERAX BIOMEDICAL INC
/s/ James Lousararian
James Lousararian
Chief Executive Officer
2019-09-18